London, April 25, 2023 — Dr Arne Scheu, CEO of LiliumX, has been invited to showcase LiliumX’s at Biotrinity 2023. During the R&D Spotlight: Platforms session, Arne will showcase LiliumX’s Universal Assembly Platform for rapid generation and screening of antibody-based drug candidates. He will further discuss LiliumX’s development on novel multivalent antibody formats and their use in antagonists and agonists, as well as their integration with bispecificity to generate new and improved treatments.

The event is held April 25-April 26 in London. To learn more about BioTrinity 2023, visit https://obn.glueup.com/event/biotrinity-2023-57830/programme.html. For more information about LiliumX, visit www.liliumx.com or reach out at info@liliumx.com.